{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:13:09Z","timestamp":1760044389021,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T00:00:00Z","timestamp":1489536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201294"],"award-info":[{"award-number":["81201294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"47th Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, 2nd degree"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12253-017-0213-7","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T10:04:39Z","timestamp":1489572279000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pathological Findings in Myasthenia Gravis Patients with Thymic Hyperplasia and Thymoma"],"prefix":"10.1007","volume":"24","author":[{"given":"Ping","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-lei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-Min","family":"Qu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,3,15]]},"reference":[{"issue":"10","key":"213_CR1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","volume":"2","author":"A Vincent","year":"2002","unstructured":"Vincent A (2002) Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol 2(10):797\u2013804","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"213_CR2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2012.02.121","volume":"420","author":"B Moser","year":"2012","unstructured":"Moser B, Bekos C, Zimprich F, Nickl S, Klepetko W, Ankersmit J (2012) The receptor for advanced glycation end products and its ligands in patients with myasthenia gravis. Biochem Biophys Res Commun 420(1):96\u2013101","journal-title":"Biochem Biophys Res Commun"},{"key":"213_CR3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","volume":"52","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun 52:90\u2013100","journal-title":"J Autoimmun"},{"key":"213_CR4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1212\/WNL.55.1.7","volume":"55","author":"GS Gronseth","year":"2000","unstructured":"Gronseth GS, Barohn R (2000) Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review). Report from the quality standards subcommittee of the American academy of neurology. Neurology 55:7\u201315","journal-title":"Neurology"},{"issue":"8","key":"213_CR5","first-page":"464","volume":"114","author":"V Bak","year":"2013","unstructured":"Bak V, Spalek P, Petrovajova T, Vichova B, Oravsky M, Luha J, Schnorrer M (2013) Thymic tumours associated with Myasthenia gravis: a long term observation study of operated patients. Bratisl Lek Listy 114(8):464\u2013468","journal-title":"Bratisl Lek Listy"},{"issue":"4","key":"213_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/mus.22103","volume":"44","author":"P Cavalcante","year":"2011","unstructured":"Cavalcante P, Le Panse R, Berrih-Aknin S, Maggi L, Antozzi C, Baggi F, Bernasconi P, Mantegazza R (2011) The thymus in myasthenia gravis: site of \"innate autoimmunity\"? Muscle Nerve 44(4):467\u2013484","journal-title":"Muscle Nerve"},{"issue":"4","key":"213_CR7","first-page":"452","volume":"66","author":"KI Geuder","year":"1992","unstructured":"Geuder KI, Marx A, Witzemann V, Schalke B, Kirchner T, M\u00fcller-Hermelink HK (1992) Genomic organization and lack of transcription of the nicotinic acetylcholine receptor subunit genes in myasthenia gravis-associated thymoma. Lab Investig 66(4):452\u2013458","journal-title":"Lab Investig"},{"issue":"12","key":"213_CR8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1097\/JTO.0000000000000370","volume":"9","author":"A Sandri","year":"2014","unstructured":"Sandri A, Cusumano G, Lococo F et al (2014) Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol 9(12):1796\u20131804","journal-title":"J Thorac Oncol"},{"key":"213_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2015.03.018","volume":"282","author":"RH De Meel","year":"2015","unstructured":"De Meel RH, Lipka AF, Van Zwet EW, Niks EH, Verschuuren JJ (2015) Prognostic factors for exacerbations and emergency treatments in myasthenia gravis. J Neuroimmunol 282:123\u2013125","journal-title":"J Neuroimmunol"},{"issue":"7","key":"213_CR10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/JTO.0000000000000215","volume":"9","author":"N Safieddine","year":"2014","unstructured":"Safieddine N, Liu G, Cuningham K et al (2014) Prognostic factors for cure, recurrence and long-term survival after surgical resection of thymoma. J Thorac Oncol 9(7):1018\u20131022","journal-title":"J Thorac Oncol"},{"issue":"4","key":"213_CR11","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00415-015-7673-z","volume":"262","author":"A Uzawa","year":"2015","unstructured":"Uzawa A, Kawaguchi N, Kanai T et al (2015) Two-year outcome of thymectomy in non-thymomatous late-onset myasthenia gravis. J Neurol 262(4):1019\u20131023","journal-title":"J Neurol"},{"issue":"9","key":"213_CR12","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.4049\/jimmunol.166.9.5464","volume":"166","author":"HS Azzam","year":"2001","unstructured":"Azzam HS, DeJarnette JB, Huang K et al (2001) Fine tuning of TCR signaling by CD5. J Immunol 166(9):5464\u20135472","journal-title":"J Immunol"},{"issue":"5223","key":"213_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1126\/science.7542801","volume":"269","author":"A Tarakhovsky","year":"1995","unstructured":"Tarakhovsky A, Kanner SB, Hombach J et al (1995) A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 269(5223):535\u2013537","journal-title":"Science"},{"issue":"5","key":"213_CR14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/WNL.42.5.1076","volume":"42","author":"S Ragheb","year":"1992","unstructured":"Ragheb S, Lisak RP (1992) Effect of clinical status and treatment on the frequency of CD5+ B cells in patients with myasthenia gravis. Neurology 42(5):1076\u20131080","journal-title":"Neurology"},{"issue":"4","key":"213_CR15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.autrev.2008.11.007","volume":"8","author":"A Dalloul","year":"2009","unstructured":"Dalloul A (2009) CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev 8(4):349\u2013353","journal-title":"Autoimmun Rev"},{"issue":"7","key":"213_CR16","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/WNL.40.7.1120","volume":"40","author":"S Ragheb","year":"1990","unstructured":"Ragheb S, Lisak RP (1990) The frequency of CD5+ B lymphocytes in the peripheral blood of patients with myasthenia gravis. Neurology 40(7):1120\u20131124","journal-title":"Neurology"},{"issue":"10","key":"213_CR17","doi-asserted-by":"crossref","first-page":"7021","DOI":"10.4049\/jimmunol.175.10.7021","volume":"175","author":"M Colombara","year":"2005","unstructured":"Colombara M, Antonini V, Riviera AP et al (2005) Constitutive activation of p38 and ERK1\/2 MAPKs in epithelial cells of myasthenic thymus leads to IL-6 and RANTES overexpression: effects on survival and migration of peripheral T and B cells. J Immunol 175(10):7021\u20137028","journal-title":"J Immunol"},{"issue":"11","key":"213_CR18","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.4049\/jimmunol.178.11.6821","volume":"178","author":"G Friedlein","year":"2007","unstructured":"Friedlein G, El Hage F, Vergnon I et al (2007) Human CD5 protects circulating tumor antigen-specific CTL from tumor-mediated activation-induced cell death. J Immunol 178(11):6821\u20136827","journal-title":"J Immunol"},{"issue":"4","key":"213_CR19","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar2795","volume":"11","author":"SK Lundy","year":"2009","unstructured":"Lundy SK, Fox DA (2009) Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. Arthritis Res Ther 11(4):R128","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"213_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2567.2006.02398.x","volume":"118","author":"BV Aruna","year":"2006","unstructured":"Aruna BV, Ben-David H, Sela M et al (2006) A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas\u2013FasL-mediated apoptosis. Immunology 118(3):413\u2013424","journal-title":"Immunology"},{"key":"213_CR21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.191.6.1017","volume":"191","author":"J Zhang","year":"2000","unstructured":"Zhang J, Gao JX, Salojin K et al (2000) Regulation of Fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase. Exp Med 191:1017\u20131030","journal-title":"Exp Med"},{"key":"213_CR22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","volume":"407","author":"PH Krammer","year":"2000","unstructured":"Krammer PH (2000) CD95's deadly mission in the immune system. Nature 407:789\u2013495","journal-title":"Nature"},{"key":"213_CR23","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.4049\/jimmunol.169.11.6218","volume":"169","author":"WF Davidson","year":"2002","unstructured":"Davidson WF, Haudenschild C, Kwon J, Williams MS (2002) T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent. J Immunol 169:6218\u20136230","journal-title":"J Immunol"},{"issue":"1","key":"213_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","volume":"70","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki A 3rd, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, Sanders DB (2000) Myasthenia gravis: recommendations for clinical research standards. J Ann Thorac Surg 70(1):327\u2013334","journal-title":"J Ann Thorac Surg"},{"key":"213_CR25","first-page":"2076","volume":"61","author":"KE Osserman","year":"1961","unstructured":"Osserman KE, Genkins G (1961) Studies in myasthenia gravis. N Y State J Med 61:2076\u20132085","journal-title":"N Y State J Med"},{"issue":"Suppl 7","key":"213_CR26","first-page":"472","volume":"73","author":"H Murai","year":"2015","unstructured":"Murai H (2015) Myasthenia gravis: epidemiology and prognosis. Nihon Rinsho 73(Suppl 7):472\u2013476","journal-title":"Nihon Rinsho"},{"issue":"11","key":"213_CR27","first-page":"1047","volume":"l52","author":"K Utsugisawa","year":"2012","unstructured":"Utsugisawa K, Nagane Y, Suzuki S, Suzuki N (2012) Directions for use of corticosteroids and calcineurin inhibitors against generalized myasthenia gravis: therapeutic strategies that can lead to early improvements and veer away from high-dose oral corticosteroids. Clin Neuro l52(11):1047\u20131050","journal-title":"Clin Neuro"},{"issue":"4","key":"213_CR28","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3988\/jcn.2011.7.4.173","volume":"7","author":"JY Kim","year":"2011","unstructured":"Kim JY, Park KD, Richman DP (2011) Treatment of myasthenia gravis based on its immunopathogenesis. J Clin Neurol 7(4):173\u2013183","journal-title":"J Clin Neurol"},{"issue":"3","key":"213_CR29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/icvts\/ivt510","volume":"18","author":"A Diaz","year":"2014","unstructured":"Diaz A, Black E, Dunning J (2014) Is thymectomy in non-thymomatous myasthenia gravis of any benefit? Interact Cardiovasc Thorac Surg 18(3):381\u2013389","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"5\u20136","key":"213_CR30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","volume":"43","author":"R Le Panse","year":"2010","unstructured":"Le Panse R, Bismuth J, Cizeron-Clairac G et al (2010) Thymic remodeling associated with hyperplasia in myasthenia gravis. Autoimmunity 43(5\u20136):401\u2013412","journal-title":"Autoimmunity"},{"issue":"5","key":"213_CR31","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/WNL.42.5.1081","volume":"42","author":"Q Yi","year":"1992","unstructured":"Yi Q, Ahlberg R, Pirskanen R, Lefvert AK (1992) Levels of CD5+ B lymphocytes do not differ between patients with myasthenia gravis and healthy individuals. Neurology 42(5):1081\u20131084","journal-title":"Neurology"},{"issue":"3","key":"213_CR32","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2567.2006.02398.x","volume":"118","author":"BV Aruna","year":"2006","unstructured":"Aruna BV, Ben-David H, Sela M, Mozes E (2006) A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas-FasL-mediated apoptosis. Immunology 118(3):413\u2013424","journal-title":"Immunology"},{"issue":"4","key":"213_CR33","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1159\/000331959","volume":"l42","author":"HJ Shin","year":"1998","unstructured":"Shin HJ, Katz RL (1998) Thymic neoplasia as represented by fine needle aspiration biopsy of anterior mediastinal masses. A practical approach to the differential diagnosis. Acta Cyto l42(4):855\u2013864","journal-title":"Acta Cyto"},{"key":"213_CR34","doi-asserted-by":"crossref","unstructured":"Li H, Wang DL, Liu XW, Geng ZJ, Xie CM (2013) Computed tomography characterization of neuroendocrine tumors of the thymus can aid identification and treatment. Acta Radio l54(2):175\u2013180","DOI":"10.1258\/ar.2012.120298"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-017-0213-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-017-0213-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T06:24:05Z","timestamp":1513664645000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-017-0213-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,15]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["213"],"URL":"https:\/\/doi.org\/10.1007\/s12253-017-0213-7","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"type":"print","value":"1219-4956"},{"type":"electronic","value":"1532-2807"}],"subject":[],"published":{"date-parts":[[2017,3,15]]}}}